Figure 2
Figure 2. The Hippo pathway. In mammalian cells, the Hippo pathway kinase cascade inhibits YAP by direct phosphorylation of YAP by Lats to generate a 14-3-3–binding site that induces YAP cytoplasmic translocation and inactivation. Evidence to support the role of YAP as an oncogene is listed. Ex indicates Expanded; Mer, Merlin, also called NF2; Mst, Mst1/2, also called STK4 and STK3, Hpo homolog; WW45, Sav homolog; Mob, Mps 1 binder kinase activator-like 1A/B, MOBKL1A/B, Mats homolog; Lats, Lats1/2, Wts homolog; YAP, Yes-associated protein, Yki homolog; TAZ, transcriptional coactivator with PDZ-binding motif, also called WWTR1, Yki homolog; and TEAD, TEA domain family member 1/2/3/4. Dashed arrows indicate unknown biochemical mechanism and question marks denote unknown components. Adapted from Zhao et al7 with permission. Professional illustration by Debra T. Dartez.

The Hippo pathway. In mammalian cells, the Hippo pathway kinase cascade inhibits YAP by direct phosphorylation of YAP by Lats to generate a 14-3-3–binding site that induces YAP cytoplasmic translocation and inactivation. Evidence to support the role of YAP as an oncogene is listed. Ex indicates Expanded; Mer, Merlin, also called NF2; Mst, Mst1/2, also called STK4 and STK3, Hpo homolog; WW45, Sav homolog; Mob, Mps 1 binder kinase activator-like 1A/B, MOBKL1A/B, Mats homolog; Lats, Lats1/2, Wts homolog; YAP, Yes-associated protein, Yki homolog; TAZ, transcriptional coactivator with PDZ-binding motif, also called WWTR1, Yki homolog; and TEAD, TEA domain family member 1/2/3/4. Dashed arrows indicate unknown biochemical mechanism and question marks denote unknown components. Adapted from Zhao et al with permission. Professional illustration by Debra T. Dartez.

Close Modal

or Create an Account

Close Modal
Close Modal